Related Experiment Video
Updated: Jun 28, 2026

Subjective Refraction Test Using a Smartphone for Vision Screening
Published on: October 18, 2024
Visual and refractive outcomes of retinopathy of prematurity in school-age patients
Yi-Hsuan Tseng1, Wei-Yu Wang2, Pei-Liang Wu3
1Department of Medicine, Mackay Medical University, New Taipei City, 252, Taiwan.
Insights
Retinopathy of prematurity (ROP) and its treatments impact ocular development. Laser treatment led to more myopia and astigmatism, while anti-VEGF injections showed outcomes similar to untreated ROP.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Retinal Diseases
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Understanding the long-term ocular and refractive outcomes of ROP and its treatments is crucial for patient management.
Purpose of the Study:
- To evaluate visual and refractive outcomes in school-aged patients with a history of prematurity and ROP.
- To compare outcomes between different ROP treatment modalities (laser vs. anti-VEGF) and untreated ROP.
Main Methods:
- Retrospective cross-sectional study of 310 patients categorized into five groups: full-term, preterm without ROP, untreated ROP, IVI-treated ROP, and LIO-treated ROP.
- Comprehensive ophthalmic examinations including cycloplegic refraction and optical biometry.
- Comparisons stratified into two age cohorts (5-9 and 10-13 years) assessing refractive errors, axial length (AL), anterior chamber depth (ACD), and corneal parameters.
Main Results:
- Significant intergroup differences in AL, ACD, corneal diameter, and best-corrected visual acuity (BCVA) were observed.
- Laser indirect ophthalmoscopy (LIO)-treated eyes in older cohorts showed shorter AL, shallower ACD, smaller corneal diameter, and steeper corneal curvature compared to full-term controls.
- Intravitreal injection of anti-VEGF (IVI)-treated eyes had biometric and refractive profiles similar to untreated ROP.
Conclusions:
- ROP and its treatments have lasting effects on ocular development and refractive status.
- Laser treatment for ROP is associated with increased myopia, astigmatism, shorter AL, shallower ACD, and smaller corneal diameters, especially in older children.
- IVI treatment for ROP resulted in ocular biometry closer to that of untreated ROP, suggesting potentially different long-term impacts compared to laser therapy.
Purpose:
To evaluate visual and refractive outcomes in school-aged patients with a history of prematurity and retinopathy of prematurity (ROP) with or without treatment.
Methods:
This is a retrospective cross-sectional study. Participants were categorized into five groups: full-term, preterm without ROP, ROP without treatment, intravitreal injection of anti-vascular endothelial growth factor (IVI)-treated ROP, and laser indirect ophthalmoscopy (LIO)-treated ROP. Patients underwent comprehensive ophthalmic examinations, including cycloplegic refraction and optical biometry. Comparisons were stratified into two age cohorts: 5 ≤ AGE < 10 and 10 ≤ AGE ≤ 13. Refractive errors, axial length (AL), anterior chamber depth (ACD), corneal parameters, and lens thickness were measured and compared between the groups.
Results:
A total of 310 patients were enrolled in the study. Significant intergroup differences in AL, ACD, white-to-white distance, and best-corrected visual acuity (BCVA) were observed across both age cohorts (all p < 0.05). In the older age cohort, post-hoc analysis revealed that LIO-treated eyes had significantly shorter AL (22.73 ± 1.51 mm vs. 24.39 ± 0.89 mm, p = 0.0057), shallower ACD (3.31 ± 0.46 mm vs. 3.78 ± 0.22 mm), smaller corneal diameter (11.53 ± 0.35 mm vs. 12.29 ± 0.42 mm, p = 0.0018), and steeper corneal curvature (46.23 ± 1.53 D vs. 42.95 ± 1.37 D, p = 0.0002) compared with full-term controls. When directly compared with IVI-treated eyes in the older cohort, LIO-treated eyes had significantly thinner corneas (p = 0.04) and steeper corneal curvature (p = 0.005). IVI-treated eyes exhibited biometric and refractive profiles similar to those of untreated ROP.
Conclusion:
ROP and its treatment have long-term effects on ocular development and refraction. Laser-treated patients exhibited significantly higher myopia and astigmatism, shorter axial length, shallower anterior chambers, and smaller corneal diameters, particularly in older age groups. In contrast, IVI-treated eyes had a biometry closer to that of untreated ROP.
Related Concept Videos
Diabetic Retinopathy
Photoreceptors and Visual Pathways
